nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA7—colon cancer	0.717	1	CbGaD
Topiramate—GRIK4—renal system—colon cancer	0.00339	0.107	CbGeAlD
Topiramate—CA9—gall bladder—colon cancer	0.0022	0.0698	CbGeAlD
Topiramate—GRIK3—vagina—colon cancer	0.00179	0.0567	CbGeAlD
Topiramate—GRIK1—vagina—colon cancer	0.0017	0.0539	CbGeAlD
Topiramate—GRIA3—liver—colon cancer	0.00133	0.0423	CbGeAlD
Topiramate—GRIA2—embryo—colon cancer	0.00122	0.0388	CbGeAlD
Topiramate—CA7—renal system—colon cancer	0.0012	0.0381	CbGeAlD
Topiramate—GRIK5—lymph node—colon cancer	0.00116	0.0367	CbGeAlD
Topiramate—GRIK3—lymph node—colon cancer	0.00116	0.0367	CbGeAlD
Topiramate—CA5A—liver—colon cancer	0.00111	0.035	CbGeAlD
Topiramate—CA7—digestive system—colon cancer	0.000988	0.0313	CbGeAlD
Topiramate—CA9—digestive system—colon cancer	0.000867	0.0275	CbGeAlD
Topiramate—CA2—gall bladder—colon cancer	0.000837	0.0265	CbGeAlD
Topiramate—CA12—renal system—colon cancer	0.000782	0.0248	CbGeAlD
Topiramate—CA12—digestive system—colon cancer	0.000642	0.0203	CbGeAlD
Topiramate—CA1—renal system—colon cancer	0.00062	0.0196	CbGeAlD
Topiramate—SCN5A—digestive system—colon cancer	0.000558	0.0177	CbGeAlD
Topiramate—CA2—embryo—colon cancer	0.000531	0.0168	CbGeAlD
Topiramate—CA1—lymphoid tissue—colon cancer	0.000515	0.0163	CbGeAlD
Topiramate—CA1—digestive system—colon cancer	0.000508	0.0161	CbGeAlD
Topiramate—CA5B—vagina—colon cancer	0.000508	0.0161	CbGeAlD
Topiramate—SCN5A—vagina—colon cancer	0.000492	0.0156	CbGeAlD
Topiramate—CA4—renal system—colon cancer	0.000484	0.0153	CbGeAlD
Topiramate—CA1—bone marrow—colon cancer	0.000468	0.0148	CbGeAlD
Topiramate—CA2—epithelium—colon cancer	0.000433	0.0137	CbGeAlD
Topiramate—CA2—smooth muscle tissue—colon cancer	0.000417	0.0132	CbGeAlD
Topiramate—CA2—renal system—colon cancer	0.000402	0.0127	CbGeAlD
Topiramate—CA4—digestive system—colon cancer	0.000397	0.0126	CbGeAlD
Topiramate—CA1—liver—colon cancer	0.000379	0.012	CbGeAlD
Topiramate—CA4—bone marrow—colon cancer	0.000366	0.0116	CbGeAlD
Topiramate—CYP2C19—digestive system—colon cancer	0.000359	0.0114	CbGeAlD
Topiramate—CA2—lymphoid tissue—colon cancer	0.000333	0.0106	CbGeAlD
Topiramate—CA2—digestive system—colon cancer	0.000329	0.0104	CbGeAlD
Topiramate—CA5B—lymph node—colon cancer	0.000329	0.0104	CbGeAlD
Topiramate—CYP2C19—vagina—colon cancer	0.000317	0.0101	CbGeAlD
Topiramate—CA2—bone marrow—colon cancer	0.000304	0.00962	CbGeAlD
Topiramate—CA2—vagina—colon cancer	0.000291	0.00921	CbGeAlD
Topiramate—CA1—lymph node—colon cancer	0.00029	0.00919	CbGeAlD
Topiramate—CYP2C19—liver—colon cancer	0.000268	0.00848	CbGeAlD
Topiramate—CYP3A4—renal system—colon cancer	0.000259	0.0082	CbGeAlD
Topiramate—CA2—liver—colon cancer	0.000245	0.00777	CbGeAlD
Topiramate—CA4—lymph node—colon cancer	0.000227	0.00719	CbGeAlD
Topiramate—CYP3A4—digestive system—colon cancer	0.000213	0.00673	CbGeAlD
Topiramate—CA2—lymph node—colon cancer	0.000188	0.00596	CbGeAlD
Topiramate—CYP3A4—liver—colon cancer	0.000158	0.00501	CbGeAlD
Topiramate—CA5A—Metabolism—ODC1—colon cancer	0.000155	0.00142	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—SRC—colon cancer	0.000148	0.00135	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—PTGS2—colon cancer	0.000148	0.00135	CbGpPWpGaD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000146	0.00134	CbGpPWpGaD
Topiramate—CA7—Metabolism—CHST5—colon cancer	0.000145	0.00133	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ODC1—colon cancer	0.000145	0.00133	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CHST5—colon cancer	0.000145	0.00133	CbGpPWpGaD
Topiramate—CA7—Metabolism—ODC1—colon cancer	0.000145	0.00133	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—APC—colon cancer	0.000144	0.00132	CbGpPWpGaD
Topiramate—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000144	0.00131	CbGpPWpGaD
Topiramate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000143	0.00131	CbGpPWpGaD
Topiramate—CA9—Metabolism—CA7—colon cancer	0.000143	0.00131	CbGpPWpGaD
Topiramate—GRIA2—N-cadherin signaling events—PIK3CA—colon cancer	0.000143	0.00131	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	0.00014	0.00128	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—HRAS—colon cancer	0.000139	0.00127	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—HRAS—colon cancer	0.000139	0.00127	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.000138	0.00127	CbGpPWpGaD
Topiramate—CA12—Metabolism—ODC1—colon cancer	0.000134	0.00123	CbGpPWpGaD
Topiramate—CA12—Metabolism—CHST5—colon cancer	0.000134	0.00123	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CCND1—colon cancer	0.000133	0.00122	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—BRAF—colon cancer	0.000133	0.00122	CbGpPWpGaD
Topiramate—Hypotension—Vincristine—colon cancer	0.000131	0.000924	CcSEcCtD
Topiramate—Bradycardia—Capecitabine—colon cancer	0.000131	0.000924	CcSEcCtD
Topiramate—Oedema—Fluorouracil—colon cancer	0.000131	0.000923	CcSEcCtD
Topiramate—CA9—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000131	0.0012	CbGpPWpGaD
Topiramate—Anorexia—Irinotecan—colon cancer	0.00013	0.000918	CcSEcCtD
Topiramate—Ataxia—Methotrexate—colon cancer	0.00013	0.000918	CcSEcCtD
Topiramate—Infection—Fluorouracil—colon cancer	0.00013	0.000917	CcSEcCtD
Topiramate—Haemoglobin—Capecitabine—colon cancer	0.000129	0.000912	CcSEcCtD
Topiramate—GRIK1—Transmission across Chemical Synapses—HRAS—colon cancer	0.000129	0.00118	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—HRAS—colon cancer	0.000129	0.00118	CbGpPWpGaD
Topiramate—Rhinitis—Capecitabine—colon cancer	0.000129	0.00091	CcSEcCtD
Topiramate—CA1—C-MYB transcription factor network—CDKN1A—colon cancer	0.000129	0.00118	CbGpPWpGaD
Topiramate—Hepatitis—Capecitabine—colon cancer	0.000129	0.000907	CcSEcCtD
Topiramate—Haemorrhage—Capecitabine—colon cancer	0.000129	0.000907	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—DCC—colon cancer	0.000129	0.00118	CbGpPWpGaD
Topiramate—Nervous system disorder—Fluorouracil—colon cancer	0.000128	0.000905	CcSEcCtD
Topiramate—Thrombocytopenia—Fluorouracil—colon cancer	0.000128	0.000903	CcSEcCtD
Topiramate—Hypoaesthesia—Capecitabine—colon cancer	0.000128	0.000903	CcSEcCtD
Topiramate—Liver function test abnormal—Methotrexate—colon cancer	0.000128	0.000902	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000128	0.000901	CcSEcCtD
Topiramate—Pharyngitis—Capecitabine—colon cancer	0.000128	0.000901	CcSEcCtD
Topiramate—Tachycardia—Fluorouracil—colon cancer	0.000128	0.0009	CcSEcCtD
Topiramate—Hypotension—Irinotecan—colon cancer	0.000128	0.0009	CcSEcCtD
Topiramate—Urinary tract disorder—Capecitabine—colon cancer	0.000127	0.000896	CcSEcCtD
Topiramate—Insomnia—Vincristine—colon cancer	0.000127	0.000895	CcSEcCtD
Topiramate—Oedema peripheral—Capecitabine—colon cancer	0.000127	0.000894	CcSEcCtD
Topiramate—SCN5A—Axon guidance—DCC—colon cancer	0.000127	0.00116	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.000127	0.00116	CbGpPWpGaD
Topiramate—Connective tissue disorder—Capecitabine—colon cancer	0.000127	0.000892	CcSEcCtD
Topiramate—Urethral disorder—Capecitabine—colon cancer	0.000126	0.00089	CcSEcCtD
Topiramate—Paraesthesia—Vincristine—colon cancer	0.000126	0.000888	CcSEcCtD
Topiramate—Breast disorder—Methotrexate—colon cancer	0.000125	0.000882	CcSEcCtD
Topiramate—Anorexia—Fluorouracil—colon cancer	0.000125	0.000879	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000125	0.000879	CcSEcCtD
Topiramate—Visual impairment—Capecitabine—colon cancer	0.000124	0.000875	CcSEcCtD
Topiramate—CA9—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000124	0.00113	CbGpPWpGaD
Topiramate—Insomnia—Irinotecan—colon cancer	0.000124	0.000871	CcSEcCtD
Topiramate—Paraesthesia—Irinotecan—colon cancer	0.000123	0.000865	CcSEcCtD
Topiramate—CA1—C-MYB transcription factor network—EP300—colon cancer	0.000123	0.00112	CbGpPWpGaD
Topiramate—Hypotension—Fluorouracil—colon cancer	0.000122	0.000862	CcSEcCtD
Topiramate—Decreased appetite—Vincristine—colon cancer	0.000122	0.00086	CcSEcCtD
Topiramate—Dyspnoea—Irinotecan—colon cancer	0.000122	0.000859	CcSEcCtD
Topiramate—Erythema multiforme—Capecitabine—colon cancer	0.000122	0.000858	CcSEcCtD
Topiramate—Somnolence—Irinotecan—colon cancer	0.000122	0.000856	CcSEcCtD
Topiramate—Gastrointestinal disorder—Vincristine—colon cancer	0.000121	0.000854	CcSEcCtD
Topiramate—Fatigue—Vincristine—colon cancer	0.000121	0.000853	CcSEcCtD
Topiramate—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000121	0.0011	CbGpPWpGaD
Topiramate—Eye disorder—Capecitabine—colon cancer	0.00012	0.000848	CcSEcCtD
Topiramate—Dyspepsia—Irinotecan—colon cancer	0.00012	0.000848	CcSEcCtD
Topiramate—Tinnitus—Capecitabine—colon cancer	0.00012	0.000846	CcSEcCtD
Topiramate—Pain—Vincristine—colon cancer	0.00012	0.000846	CcSEcCtD
Topiramate—Constipation—Vincristine—colon cancer	0.00012	0.000846	CcSEcCtD
Topiramate—Asthma—Methotrexate—colon cancer	0.00012	0.000844	CcSEcCtD
Topiramate—Flushing—Capecitabine—colon cancer	0.00012	0.000842	CcSEcCtD
Topiramate—Cardiac disorder—Capecitabine—colon cancer	0.00012	0.000842	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000119	0.000841	CcSEcCtD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—colon cancer	0.000119	0.00109	CbGpPWpGaD
Topiramate—Decreased appetite—Irinotecan—colon cancer	0.000119	0.000837	CcSEcCtD
Topiramate—Eosinophilia—Methotrexate—colon cancer	0.000119	0.000836	CcSEcCtD
Topiramate—Insomnia—Fluorouracil—colon cancer	0.000118	0.000834	CcSEcCtD
Topiramate—Gastrointestinal disorder—Irinotecan—colon cancer	0.000118	0.000832	CcSEcCtD
Topiramate—Fatigue—Irinotecan—colon cancer	0.000118	0.00083	CcSEcCtD
Topiramate—Paraesthesia—Fluorouracil—colon cancer	0.000118	0.000828	CcSEcCtD
Topiramate—Pancreatitis—Methotrexate—colon cancer	0.000117	0.000827	CcSEcCtD
Topiramate—Constipation—Irinotecan—colon cancer	0.000117	0.000824	CcSEcCtD
Topiramate—Pain—Irinotecan—colon cancer	0.000117	0.000824	CcSEcCtD
Topiramate—Angiopathy—Capecitabine—colon cancer	0.000117	0.000823	CcSEcCtD
Topiramate—Dyspnoea—Fluorouracil—colon cancer	0.000117	0.000823	CcSEcCtD
Topiramate—Somnolence—Fluorouracil—colon cancer	0.000116	0.00082	CcSEcCtD
Topiramate—Immune system disorder—Capecitabine—colon cancer	0.000116	0.00082	CcSEcCtD
Topiramate—Mediastinal disorder—Capecitabine—colon cancer	0.000116	0.000818	CcSEcCtD
Topiramate—Chills—Capecitabine—colon cancer	0.000116	0.000814	CcSEcCtD
Topiramate—Dyspepsia—Fluorouracil—colon cancer	0.000115	0.000812	CcSEcCtD
Topiramate—Abdominal discomfort—Methotrexate—colon cancer	0.000115	0.000809	CcSEcCtD
Topiramate—CA1—C-MYB transcription factor network—NRAS—colon cancer	0.000115	0.00105	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Vincristine—colon cancer	0.000115	0.000809	CcSEcCtD
Topiramate—Decreased appetite—Fluorouracil—colon cancer	0.000114	0.000802	CcSEcCtD
Topiramate—Alopecia—Capecitabine—colon cancer	0.000114	0.000802	CcSEcCtD
Topiramate—Pancytopenia—Methotrexate—colon cancer	0.000114	0.000801	CcSEcCtD
Topiramate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000113	0.000797	CcSEcCtD
Topiramate—Mental disorder—Capecitabine—colon cancer	0.000113	0.000795	CcSEcCtD
Topiramate—Feeling abnormal—Irinotecan—colon cancer	0.000113	0.000794	CcSEcCtD
Topiramate—Malnutrition—Capecitabine—colon cancer	0.000112	0.00079	CcSEcCtD
Topiramate—Erythema—Capecitabine—colon cancer	0.000112	0.00079	CcSEcCtD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—TGFB1—colon cancer	0.000112	0.00103	CbGpPWpGaD
Topiramate—Dysuria—Methotrexate—colon cancer	0.000112	0.000789	CcSEcCtD
Topiramate—Neutropenia—Methotrexate—colon cancer	0.000112	0.000789	CcSEcCtD
Topiramate—Pain—Fluorouracil—colon cancer	0.000112	0.000789	CcSEcCtD
Topiramate—Gastrointestinal pain—Irinotecan—colon cancer	0.000112	0.000788	CcSEcCtD
Topiramate—Upper respiratory tract infection—Methotrexate—colon cancer	0.000111	0.000784	CcSEcCtD
Topiramate—Body temperature increased—Vincristine—colon cancer	0.000111	0.000782	CcSEcCtD
Topiramate—Abdominal pain—Vincristine—colon cancer	0.000111	0.000782	CcSEcCtD
Topiramate—SCN1A—L1CAM interactions—SRC—colon cancer	0.000111	0.00101	CbGpPWpGaD
Topiramate—Flatulence—Capecitabine—colon cancer	0.00011	0.000778	CcSEcCtD
Topiramate—Erectile dysfunction—Methotrexate—colon cancer	0.00011	0.000777	CcSEcCtD
Topiramate—GRIA4—Transmission across Chemical Synapses—HRAS—colon cancer	0.00011	0.00101	CbGpPWpGaD
Topiramate—Dysgeusia—Capecitabine—colon cancer	0.00011	0.000774	CcSEcCtD
Topiramate—Photosensitivity reaction—Methotrexate—colon cancer	0.000109	0.00077	CcSEcCtD
Topiramate—Back pain—Capecitabine—colon cancer	0.000108	0.000764	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—HNF4A—colon cancer	0.000108	0.000991	CbGpPWpGaD
Topiramate—Abdominal pain—Irinotecan—colon cancer	0.000108	0.000761	CcSEcCtD
Topiramate—Body temperature increased—Irinotecan—colon cancer	0.000108	0.000761	CcSEcCtD
Topiramate—Feeling abnormal—Fluorouracil—colon cancer	0.000108	0.00076	CcSEcCtD
Topiramate—Muscle spasms—Capecitabine—colon cancer	0.000108	0.000759	CcSEcCtD
Topiramate—Pneumonia—Methotrexate—colon cancer	0.000107	0.000757	CcSEcCtD
Topiramate—CA4—Metabolism—CHST5—colon cancer	0.000107	0.000979	CbGpPWpGaD
Topiramate—CA4—Metabolism—ODC1—colon cancer	0.000107	0.000979	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—MYC—colon cancer	0.000107	0.000979	CbGpPWpGaD
Topiramate—Infestation NOS—Methotrexate—colon cancer	0.000107	0.000753	CcSEcCtD
Topiramate—Infestation—Methotrexate—colon cancer	0.000107	0.000753	CcSEcCtD
Topiramate—GRIK4—Neuronal System—HRAS—colon cancer	0.000107	0.000975	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—HRAS—colon cancer	0.000107	0.000975	CbGpPWpGaD
Topiramate—Depression—Methotrexate—colon cancer	0.000106	0.00075	CcSEcCtD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000106	0.000973	CbGpPWpGaD
Topiramate—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000106	0.000746	CcSEcCtD
Topiramate—Vision blurred—Capecitabine—colon cancer	0.000106	0.000744	CcSEcCtD
Topiramate—Tremor—Capecitabine—colon cancer	0.000105	0.00074	CcSEcCtD
Topiramate—Renal failure—Methotrexate—colon cancer	0.000105	0.00074	CcSEcCtD
Topiramate—Stomatitis—Methotrexate—colon cancer	0.000104	0.000734	CcSEcCtD
Topiramate—GRIA1—Transmission across Chemical Synapses—BRAF—colon cancer	0.000104	0.000953	CbGpPWpGaD
Topiramate—Ill-defined disorder—Capecitabine—colon cancer	0.000104	0.000733	CcSEcCtD
Topiramate—Urticaria—Fluorouracil—colon cancer	0.000104	0.000733	CcSEcCtD
Topiramate—GRIA3—BDNF signaling pathway—HRAS—colon cancer	0.000104	0.000951	CbGpPWpGaD
Topiramate—Conjunctivitis—Methotrexate—colon cancer	0.000104	0.000731	CcSEcCtD
Topiramate—Anaemia—Capecitabine—colon cancer	0.000104	0.00073	CcSEcCtD
Topiramate—Body temperature increased—Fluorouracil—colon cancer	0.000104	0.000729	CcSEcCtD
Topiramate—Hypersensitivity—Vincristine—colon cancer	0.000103	0.000729	CcSEcCtD
Topiramate—CA2—Metabolism—ODC1—colon cancer	0.000103	0.000939	CbGpPWpGaD
Topiramate—CA2—Metabolism—CHST5—colon cancer	0.000103	0.000939	CbGpPWpGaD
Topiramate—Haematuria—Methotrexate—colon cancer	0.000102	0.000717	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—CASP3—colon cancer	0.000101	0.000929	CbGpPWpGaD
Topiramate—Malaise—Capecitabine—colon cancer	0.000101	0.000712	CcSEcCtD
Topiramate—Epistaxis—Methotrexate—colon cancer	0.000101	0.00071	CcSEcCtD
Topiramate—Vertigo—Capecitabine—colon cancer	0.000101	0.00071	CcSEcCtD
Topiramate—Hypersensitivity—Irinotecan—colon cancer	0.000101	0.00071	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—APC—colon cancer	0.000101	0.000922	CbGpPWpGaD
Topiramate—Asthenia—Vincristine—colon cancer	0.000101	0.00071	CcSEcCtD
Topiramate—Syncope—Capecitabine—colon cancer	0.000101	0.000708	CcSEcCtD
Topiramate—Leukopenia—Capecitabine—colon cancer	0.0001	0.000707	CcSEcCtD
Topiramate—Agranulocytosis—Methotrexate—colon cancer	9.97e-05	0.000702	CcSEcCtD
Topiramate—Palpitations—Capecitabine—colon cancer	9.91e-05	0.000698	CcSEcCtD
Topiramate—GRIK3—Neuronal System—HRAS—colon cancer	9.91e-05	0.000907	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—HRAS—colon cancer	9.91e-05	0.000907	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—KRAS—colon cancer	9.88e-05	0.000904	CbGpPWpGaD
Topiramate—Loss of consciousness—Capecitabine—colon cancer	9.85e-05	0.000694	CcSEcCtD
Topiramate—CA1—Metabolism—CHST5—colon cancer	9.83e-05	0.0009	CbGpPWpGaD
Topiramate—CA1—Metabolism—ODC1—colon cancer	9.83e-05	0.0009	CbGpPWpGaD
Topiramate—Asthenia—Irinotecan—colon cancer	9.81e-05	0.000691	CcSEcCtD
Topiramate—Cough—Capecitabine—colon cancer	9.78e-05	0.000689	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—CTNNB1—colon cancer	9.78e-05	0.000895	CbGpPWpGaD
Topiramate—SCN1A—L1CAM interactions—EGFR—colon cancer	9.72e-05	0.00089	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	9.68e-05	0.000886	CbGpPWpGaD
Topiramate—Hypertension—Capecitabine—colon cancer	9.68e-05	0.000682	CcSEcCtD
Topiramate—Hypersensitivity—Fluorouracil—colon cancer	9.65e-05	0.00068	CcSEcCtD
Topiramate—Haemoglobin—Methotrexate—colon cancer	9.64e-05	0.000679	CcSEcCtD
Topiramate—Diarrhoea—Vincristine—colon cancer	9.6e-05	0.000677	CcSEcCtD
Topiramate—Haemorrhage—Methotrexate—colon cancer	9.59e-05	0.000676	CcSEcCtD
Topiramate—Hepatitis—Methotrexate—colon cancer	9.59e-05	0.000676	CcSEcCtD
Topiramate—Chest pain—Capecitabine—colon cancer	9.54e-05	0.000673	CcSEcCtD
Topiramate—Arthralgia—Capecitabine—colon cancer	9.54e-05	0.000673	CcSEcCtD
Topiramate—Myalgia—Capecitabine—colon cancer	9.54e-05	0.000673	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—BRAF—colon cancer	9.52e-05	0.000871	CbGpPWpGaD
Topiramate—Pharyngitis—Methotrexate—colon cancer	9.51e-05	0.00067	CcSEcCtD
Topiramate—Anxiety—Capecitabine—colon cancer	9.51e-05	0.00067	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	9.48e-05	0.000668	CcSEcCtD
Topiramate—Urinary tract disorder—Methotrexate—colon cancer	9.47e-05	0.000667	CcSEcCtD
Topiramate—Discomfort—Capecitabine—colon cancer	9.43e-05	0.000664	CcSEcCtD
Topiramate—Urethral disorder—Methotrexate—colon cancer	9.4e-05	0.000662	CcSEcCtD
Topiramate—Diarrhoea—Irinotecan—colon cancer	9.35e-05	0.000659	CcSEcCtD
Topiramate—Dry mouth—Capecitabine—colon cancer	9.33e-05	0.000658	CcSEcCtD
Topiramate—Dizziness—Vincristine—colon cancer	9.28e-05	0.000654	CcSEcCtD
Topiramate—Pruritus—Fluorouracil—colon cancer	9.26e-05	0.000653	CcSEcCtD
Topiramate—Visual impairment—Methotrexate—colon cancer	9.24e-05	0.000651	CcSEcCtD
Topiramate—Confusional state—Capecitabine—colon cancer	9.23e-05	0.00065	CcSEcCtD
Topiramate—GRIA3—BDNF signaling pathway—AKT1—colon cancer	9.17e-05	0.00084	CbGpPWpGaD
Topiramate—Oedema—Capecitabine—colon cancer	9.15e-05	0.000645	CcSEcCtD
Topiramate—Infection—Capecitabine—colon cancer	9.09e-05	0.00064	CcSEcCtD
Topiramate—Erythema multiforme—Methotrexate—colon cancer	9.06e-05	0.000639	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—DCC—colon cancer	9.04e-05	0.000828	CbGpPWpGaD
Topiramate—Dizziness—Irinotecan—colon cancer	9.04e-05	0.000637	CcSEcCtD
Topiramate—Shock—Capecitabine—colon cancer	9e-05	0.000634	CcSEcCtD
Topiramate—Nervous system disorder—Capecitabine—colon cancer	8.97e-05	0.000632	CcSEcCtD
Topiramate—Eye disorder—Methotrexate—colon cancer	8.96e-05	0.000631	CcSEcCtD
Topiramate—Diarrhoea—Fluorouracil—colon cancer	8.96e-05	0.000631	CcSEcCtD
Topiramate—Thrombocytopenia—Capecitabine—colon cancer	8.96e-05	0.000631	CcSEcCtD
Topiramate—Tinnitus—Methotrexate—colon cancer	8.94e-05	0.00063	CcSEcCtD
Topiramate—Tachycardia—Capecitabine—colon cancer	8.93e-05	0.000629	CcSEcCtD
Topiramate—Vomiting—Vincristine—colon cancer	8.92e-05	0.000629	CcSEcCtD
Topiramate—Cardiac disorder—Methotrexate—colon cancer	8.9e-05	0.000627	CcSEcCtD
Topiramate—Skin disorder—Capecitabine—colon cancer	8.89e-05	0.000626	CcSEcCtD
Topiramate—Rash—Vincristine—colon cancer	8.85e-05	0.000624	CcSEcCtD
Topiramate—Hyperhidrosis—Capecitabine—colon cancer	8.84e-05	0.000623	CcSEcCtD
Topiramate—Dermatitis—Vincristine—colon cancer	8.84e-05	0.000623	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—SRC—colon cancer	8.84e-05	0.000809	CbGpPWpGaD
Topiramate—Headache—Vincristine—colon cancer	8.79e-05	0.00062	CcSEcCtD
Topiramate—Anorexia—Capecitabine—colon cancer	8.72e-05	0.000615	CcSEcCtD
Topiramate—Angiopathy—Methotrexate—colon cancer	8.7e-05	0.000613	CcSEcCtD
Topiramate—Vomiting—Irinotecan—colon cancer	8.69e-05	0.000612	CcSEcCtD
Topiramate—Immune system disorder—Methotrexate—colon cancer	8.66e-05	0.00061	CcSEcCtD
Topiramate—Dizziness—Fluorouracil—colon cancer	8.66e-05	0.00061	CcSEcCtD
Topiramate—CA9—Metabolism—ODC1—colon cancer	8.65e-05	0.000791	CbGpPWpGaD
Topiramate—CA9—Metabolism—CHST5—colon cancer	8.65e-05	0.000791	CbGpPWpGaD
Topiramate—Mediastinal disorder—Methotrexate—colon cancer	8.64e-05	0.000609	CcSEcCtD
Topiramate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	8.64e-05	0.00079	CbGpPWpGaD
Topiramate—Rash—Irinotecan—colon cancer	8.62e-05	0.000607	CcSEcCtD
Topiramate—Dermatitis—Irinotecan—colon cancer	8.61e-05	0.000607	CcSEcCtD
Topiramate—Chills—Methotrexate—colon cancer	8.6e-05	0.000606	CcSEcCtD
Topiramate—Headache—Irinotecan—colon cancer	8.56e-05	0.000603	CcSEcCtD
Topiramate—Hypotension—Capecitabine—colon cancer	8.55e-05	0.000602	CcSEcCtD
Topiramate—Alopecia—Methotrexate—colon cancer	8.47e-05	0.000597	CcSEcCtD
Topiramate—GRIA4—Neuronal System—HRAS—colon cancer	8.42e-05	0.000771	CbGpPWpGaD
Topiramate—Mental disorder—Methotrexate—colon cancer	8.4e-05	0.000592	CcSEcCtD
Topiramate—CA1—C-MYB transcription factor network—HRAS—colon cancer	8.4e-05	0.000769	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	8.39e-05	0.000768	CbGpPWpGaD
Topiramate—Malnutrition—Methotrexate—colon cancer	8.35e-05	0.000588	CcSEcCtD
Topiramate—Erythema—Methotrexate—colon cancer	8.35e-05	0.000588	CcSEcCtD
Topiramate—Nausea—Vincristine—colon cancer	8.34e-05	0.000588	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Capecitabine—colon cancer	8.34e-05	0.000587	CcSEcCtD
Topiramate—Vomiting—Fluorouracil—colon cancer	8.32e-05	0.000587	CcSEcCtD
Topiramate—Insomnia—Capecitabine—colon cancer	8.28e-05	0.000583	CcSEcCtD
Topiramate—Rash—Fluorouracil—colon cancer	8.26e-05	0.000582	CcSEcCtD
Topiramate—Dermatitis—Fluorouracil—colon cancer	8.25e-05	0.000581	CcSEcCtD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	8.23e-05	0.000753	CbGpPWpGaD
Topiramate—Paraesthesia—Capecitabine—colon cancer	8.22e-05	0.000579	CcSEcCtD
Topiramate—Headache—Fluorouracil—colon cancer	8.2e-05	0.000578	CcSEcCtD
Topiramate—Dysgeusia—Methotrexate—colon cancer	8.17e-05	0.000576	CcSEcCtD
Topiramate—Dyspnoea—Capecitabine—colon cancer	8.16e-05	0.000575	CcSEcCtD
Topiramate—Nausea—Irinotecan—colon cancer	8.12e-05	0.000572	CcSEcCtD
Topiramate—Back pain—Methotrexate—colon cancer	8.07e-05	0.000569	CcSEcCtD
Topiramate—Dyspepsia—Capecitabine—colon cancer	8.05e-05	0.000568	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—HRAS—colon cancer	7.99e-05	0.000731	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—BRAF—colon cancer	7.97e-05	0.00073	CbGpPWpGaD
Topiramate—Decreased appetite—Capecitabine—colon cancer	7.95e-05	0.00056	CcSEcCtD
Topiramate—CA9—HIF-1-alpha transcription factor network—AKT1—colon cancer	7.91e-05	0.000724	CbGpPWpGaD
Topiramate—Gastrointestinal disorder—Capecitabine—colon cancer	7.9e-05	0.000557	CcSEcCtD
Topiramate—Fatigue—Capecitabine—colon cancer	7.89e-05	0.000556	CcSEcCtD
Topiramate—Vision blurred—Methotrexate—colon cancer	7.86e-05	0.000554	CcSEcCtD
Topiramate—Constipation—Capecitabine—colon cancer	7.82e-05	0.000551	CcSEcCtD
Topiramate—Pain—Capecitabine—colon cancer	7.82e-05	0.000551	CcSEcCtD
Topiramate—SCN5A—L1CAM interactions—SRC—colon cancer	7.8e-05	0.000714	CbGpPWpGaD
Topiramate—Nausea—Fluorouracil—colon cancer	7.78e-05	0.000548	CcSEcCtD
Topiramate—Ill-defined disorder—Methotrexate—colon cancer	7.74e-05	0.000546	CcSEcCtD
Topiramate—Anaemia—Methotrexate—colon cancer	7.71e-05	0.000544	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—HNF4A—colon cancer	7.61e-05	0.000697	CbGpPWpGaD
Topiramate—Feeling abnormal—Capecitabine—colon cancer	7.54e-05	0.000531	CcSEcCtD
Topiramate—Malaise—Methotrexate—colon cancer	7.53e-05	0.00053	CcSEcCtD
Topiramate—Vertigo—Methotrexate—colon cancer	7.5e-05	0.000528	CcSEcCtD
Topiramate—Gastrointestinal pain—Capecitabine—colon cancer	7.48e-05	0.000527	CcSEcCtD
Topiramate—Leukopenia—Methotrexate—colon cancer	7.47e-05	0.000526	CcSEcCtD
Topiramate—GRIK2—Neuronal System—BRAF—colon cancer	7.29e-05	0.000668	CbGpPWpGaD
Topiramate—Cough—Methotrexate—colon cancer	7.28e-05	0.000513	CcSEcCtD
Topiramate—GRIA2—Transmission across Chemical Synapses—BRAF—colon cancer	7.28e-05	0.000666	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	7.27e-05	0.000666	CbGpPWpGaD
Topiramate—Urticaria—Capecitabine—colon cancer	7.27e-05	0.000512	CcSEcCtD
Topiramate—Abdominal pain—Capecitabine—colon cancer	7.23e-05	0.00051	CcSEcCtD
Topiramate—Body temperature increased—Capecitabine—colon cancer	7.23e-05	0.00051	CcSEcCtD
Topiramate—Convulsion—Methotrexate—colon cancer	7.23e-05	0.00051	CcSEcCtD
Topiramate—Arthralgia—Methotrexate—colon cancer	7.1e-05	0.000501	CcSEcCtD
Topiramate—Myalgia—Methotrexate—colon cancer	7.1e-05	0.000501	CcSEcCtD
Topiramate—Chest pain—Methotrexate—colon cancer	7.1e-05	0.000501	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—CASP3—colon cancer	7.1e-05	0.00065	CbGpPWpGaD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	7.06e-05	0.000497	CcSEcCtD
Topiramate—Discomfort—Methotrexate—colon cancer	7.02e-05	0.000495	CcSEcCtD
Topiramate—Confusional state—Methotrexate—colon cancer	6.87e-05	0.000484	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—CTNNB1—colon cancer	6.84e-05	0.000626	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—EGFR—colon cancer	6.83e-05	0.000625	CbGpPWpGaD
Topiramate—Infection—Methotrexate—colon cancer	6.77e-05	0.000477	CcSEcCtD
Topiramate—Hypersensitivity—Capecitabine—colon cancer	6.74e-05	0.000475	CcSEcCtD
Topiramate—Nervous system disorder—Methotrexate—colon cancer	6.68e-05	0.000471	CcSEcCtD
Topiramate—Thrombocytopenia—Methotrexate—colon cancer	6.67e-05	0.00047	CcSEcCtD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	6.65e-05	0.000609	CbGpPWpGaD
Topiramate—Skin disorder—Methotrexate—colon cancer	6.62e-05	0.000466	CcSEcCtD
Topiramate—Hyperhidrosis—Methotrexate—colon cancer	6.58e-05	0.000464	CcSEcCtD
Topiramate—Asthenia—Capecitabine—colon cancer	6.56e-05	0.000463	CcSEcCtD
Topiramate—Anorexia—Methotrexate—colon cancer	6.49e-05	0.000457	CcSEcCtD
Topiramate—Pruritus—Capecitabine—colon cancer	6.47e-05	0.000456	CcSEcCtD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	6.36e-05	0.000583	CbGpPWpGaD
Topiramate—Hypotension—Methotrexate—colon cancer	6.36e-05	0.000448	CcSEcCtD
Topiramate—Diarrhoea—Capecitabine—colon cancer	6.26e-05	0.000441	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—HRAS—colon cancer	6.22e-05	0.00057	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Methotrexate—colon cancer	6.21e-05	0.000437	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—SRC—colon cancer	6.18e-05	0.000566	CbGpPWpGaD
Topiramate—Insomnia—Methotrexate—colon cancer	6.16e-05	0.000434	CcSEcCtD
Topiramate—GRIA3—Neuronal System—HRAS—colon cancer	6.12e-05	0.00056	CbGpPWpGaD
Topiramate—Paraesthesia—Methotrexate—colon cancer	6.12e-05	0.000431	CcSEcCtD
Topiramate—Dyspnoea—Methotrexate—colon cancer	6.07e-05	0.000428	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CASP3—colon cancer	6.07e-05	0.000555	CbGpPWpGaD
Topiramate—Somnolence—Methotrexate—colon cancer	6.05e-05	0.000427	CcSEcCtD
Topiramate—Dizziness—Capecitabine—colon cancer	6.05e-05	0.000426	CcSEcCtD
Topiramate—Dyspepsia—Methotrexate—colon cancer	6e-05	0.000422	CcSEcCtD
Topiramate—Decreased appetite—Methotrexate—colon cancer	5.92e-05	0.000417	CcSEcCtD
Topiramate—Gastrointestinal disorder—Methotrexate—colon cancer	5.88e-05	0.000414	CcSEcCtD
Topiramate—Fatigue—Methotrexate—colon cancer	5.87e-05	0.000414	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—colon cancer	5.85e-05	0.000535	CbGpPWpGaD
Topiramate—Pain—Methotrexate—colon cancer	5.82e-05	0.00041	CcSEcCtD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	5.82e-05	0.000533	CbGpPWpGaD
Topiramate—Vomiting—Capecitabine—colon cancer	5.82e-05	0.00041	CcSEcCtD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	5.81e-05	0.000532	CbGpPWpGaD
Topiramate—Rash—Capecitabine—colon cancer	5.77e-05	0.000407	CcSEcCtD
Topiramate—Dermatitis—Capecitabine—colon cancer	5.76e-05	0.000406	CcSEcCtD
Topiramate—Headache—Capecitabine—colon cancer	5.73e-05	0.000404	CcSEcCtD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.72e-05	0.000524	CbGpPWpGaD
Topiramate—Feeling abnormal—Methotrexate—colon cancer	5.61e-05	0.000395	CcSEcCtD
Topiramate—GRIA2—Neuronal System—BRAF—colon cancer	5.58e-05	0.00051	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Methotrexate—colon cancer	5.57e-05	0.000392	CcSEcCtD
Topiramate—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	5.5e-05	0.000503	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—AKT1—colon cancer	5.49e-05	0.000503	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—BRAF—colon cancer	5.47e-05	0.0005	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—EP300—colon cancer	5.44e-05	0.000498	CbGpPWpGaD
Topiramate—Nausea—Capecitabine—colon cancer	5.43e-05	0.000383	CcSEcCtD
Topiramate—Urticaria—Methotrexate—colon cancer	5.41e-05	0.000381	CcSEcCtD
Topiramate—Body temperature increased—Methotrexate—colon cancer	5.38e-05	0.000379	CcSEcCtD
Topiramate—Abdominal pain—Methotrexate—colon cancer	5.38e-05	0.000379	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—VEGFA—colon cancer	5.15e-05	0.000471	CbGpPWpGaD
Topiramate—Hypersensitivity—Methotrexate—colon cancer	5.02e-05	0.000354	CcSEcCtD
Topiramate—GABRG2—Transmission across Chemical Synapses—BRAF—colon cancer	5e-05	0.000458	CbGpPWpGaD
Topiramate—Asthenia—Methotrexate—colon cancer	4.89e-05	0.000344	CcSEcCtD
Topiramate—Pruritus—Methotrexate—colon cancer	4.82e-05	0.00034	CcSEcCtD
Topiramate—GRIA1—Transmission across Chemical Synapses—HRAS—colon cancer	4.78e-05	0.000438	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—PPARG—colon cancer	4.7e-05	0.00043	CbGpPWpGaD
Topiramate—Diarrhoea—Methotrexate—colon cancer	4.66e-05	0.000328	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—CDKN1A—colon cancer	4.54e-05	0.000415	CbGpPWpGaD
Topiramate—Dizziness—Methotrexate—colon cancer	4.5e-05	0.000317	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	4.45e-05	0.000407	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—HRAS—colon cancer	4.38e-05	0.000401	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—BRAF—colon cancer	4.37e-05	0.0004	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—HRAS—colon cancer	4.35e-05	0.000398	CbGpPWpGaD
Topiramate—Vomiting—Methotrexate—colon cancer	4.33e-05	0.000305	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—EP300—colon cancer	4.32e-05	0.000395	CbGpPWpGaD
Topiramate—Rash—Methotrexate—colon cancer	4.29e-05	0.000303	CcSEcCtD
Topiramate—Dermatitis—Methotrexate—colon cancer	4.29e-05	0.000302	CcSEcCtD
Topiramate—Headache—Methotrexate—colon cancer	4.27e-05	0.000301	CcSEcCtD
Topiramate—SCN1A—Axon guidance—SRC—colon cancer	4.19e-05	0.000384	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—BRAF—colon cancer	4.19e-05	0.000383	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ABCB1—colon cancer	4.1e-05	0.000375	CbGpPWpGaD
Topiramate—CA6—Metabolism—ABCB1—colon cancer	4.1e-05	0.000375	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—VEGFA—colon cancer	4.09e-05	0.000374	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—colon cancer	4.08e-05	0.000374	CbGpPWpGaD
Topiramate—Nausea—Methotrexate—colon cancer	4.05e-05	0.000285	CcSEcCtD
Topiramate—SCN1A—Axon guidance—NRAS—colon cancer	4.03e-05	0.000369	CbGpPWpGaD
Topiramate—CA6—Metabolism—TYMS—colon cancer	4.03e-05	0.000368	CbGpPWpGaD
Topiramate—CA5A—Metabolism—TYMS—colon cancer	4.03e-05	0.000368	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CASP3—colon cancer	4e-05	0.000366	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA7—colon cancer	3.99e-05	0.000366	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	3.85e-05	0.000353	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—AKT1—colon cancer	3.84e-05	0.000352	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—BRAF—colon cancer	3.83e-05	0.000351	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ABCB1—colon cancer	3.83e-05	0.00035	CbGpPWpGaD
Topiramate—CA7—Metabolism—ABCB1—colon cancer	3.83e-05	0.00035	CbGpPWpGaD
Topiramate—CA7—Metabolism—TYMS—colon cancer	3.76e-05	0.000344	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TYMS—colon cancer	3.76e-05	0.000344	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—EGFR—colon cancer	3.67e-05	0.000336	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—HRAS—colon cancer	3.67e-05	0.000336	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—EP300—colon cancer	3.58e-05	0.000328	CbGpPWpGaD
Topiramate—CA12—Metabolism—ABCB1—colon cancer	3.55e-05	0.000325	CbGpPWpGaD
Topiramate—CA12—Metabolism—TYMS—colon cancer	3.48e-05	0.000319	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—KRAS—colon cancer	3.47e-05	0.000318	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—colon cancer	3.39e-05	0.000311	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—HRAS—colon cancer	3.35e-05	0.000307	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—BRAF—colon cancer	3.35e-05	0.000307	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—HRAS—colon cancer	3.35e-05	0.000306	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	3.34e-05	0.000306	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.32e-05	0.000304	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CTNNB1—colon cancer	3.31e-05	0.000303	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PPARG—colon cancer	3.3e-05	0.000302	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—colon cancer	3.09e-05	0.000283	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EP300—colon cancer	3.07e-05	0.000281	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	3.06e-05	0.00028	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.04e-05	0.000278	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—SRC—colon cancer	2.99e-05	0.000274	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—HRAS—colon cancer	2.95e-05	0.00027	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—SRC—colon cancer	2.95e-05	0.00027	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—colon cancer	2.91e-05	0.000267	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NRAS—colon cancer	2.88e-05	0.000263	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—colon cancer	2.87e-05	0.000263	CbGpPWpGaD
Topiramate—CA6—Metabolism—PPARG—colon cancer	2.85e-05	0.000261	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PPARG—colon cancer	2.85e-05	0.000261	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—NRAS—colon cancer	2.83e-05	0.000259	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCB1—colon cancer	2.83e-05	0.000259	CbGpPWpGaD
Topiramate—CA4—Metabolism—TYMS—colon cancer	2.78e-05	0.000254	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCB1—colon cancer	2.71e-05	0.000248	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	2.67e-05	0.000245	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TGFB1—colon cancer	2.67e-05	0.000245	CbGpPWpGaD
Topiramate—CA7—Metabolism—PPARG—colon cancer	2.66e-05	0.000244	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PPARG—colon cancer	2.66e-05	0.000244	CbGpPWpGaD
Topiramate—CA2—Metabolism—TYMS—colon cancer	2.66e-05	0.000244	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCB1—colon cancer	2.66e-05	0.000243	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—colon cancer	2.62e-05	0.00024	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCB1—colon cancer	2.6e-05	0.000238	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—colon cancer	2.58e-05	0.000236	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—HRAS—colon cancer	2.56e-05	0.000235	CbGpPWpGaD
Topiramate—CA1—Metabolism—TYMS—colon cancer	2.55e-05	0.000234	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—colon cancer	2.51e-05	0.00023	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—KRAS—colon cancer	2.48e-05	0.000227	CbGpPWpGaD
Topiramate—CA12—Metabolism—PPARG—colon cancer	2.47e-05	0.000226	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—KRAS—colon cancer	2.44e-05	0.000223	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CHST5—colon cancer	2.42e-05	0.000222	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ODC1—colon cancer	2.42e-05	0.000222	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA7—colon cancer	2.4e-05	0.00022	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CTNNB1—colon cancer	2.33e-05	0.000213	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—colon cancer	2.3e-05	0.00021	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—colon cancer	2.28e-05	0.000209	CbGpPWpGaD
Topiramate—CA9—Metabolism—TYMS—colon cancer	2.24e-05	0.000205	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—colon cancer	2.24e-05	0.000205	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—colon cancer	2.24e-05	0.000205	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EP300—colon cancer	2.16e-05	0.000198	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—colon cancer	2.1e-05	0.000193	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SRC—colon cancer	2.1e-05	0.000192	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—colon cancer	2.09e-05	0.000192	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—colon cancer	2.09e-05	0.000192	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—HRAS—colon cancer	2.07e-05	0.00019	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—colon cancer	2.05e-05	0.000187	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NRAS—colon cancer	2.02e-05	0.000185	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—colon cancer	2.01e-05	0.000184	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—colon cancer	1.97e-05	0.00018	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—colon cancer	1.94e-05	0.000178	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—colon cancer	1.93e-05	0.000176	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—colon cancer	1.89e-05	0.000173	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—colon cancer	1.88e-05	0.000172	CbGpPWpGaD
Topiramate—CA5A—Metabolism—EP300—colon cancer	1.87e-05	0.000171	CbGpPWpGaD
Topiramate—CA6—Metabolism—EP300—colon cancer	1.87e-05	0.000171	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—colon cancer	1.86e-05	0.00017	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—colon cancer	1.84e-05	0.000169	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—colon cancer	1.81e-05	0.000165	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—colon cancer	1.76e-05	0.000161	CbGpPWpGaD
Topiramate—CA7—Metabolism—EP300—colon cancer	1.74e-05	0.000159	CbGpPWpGaD
Topiramate—CA5B—Metabolism—EP300—colon cancer	1.74e-05	0.000159	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—colon cancer	1.74e-05	0.000159	CbGpPWpGaD
Topiramate—CA12—Metabolism—EP300—colon cancer	1.61e-05	0.000148	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—colon cancer	1.59e-05	0.000145	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—colon cancer	1.55e-05	0.000142	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—colon cancer	1.54e-05	0.000141	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—colon cancer	1.48e-05	0.000136	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—colon cancer	1.48e-05	0.000135	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ODC1—colon cancer	1.46e-05	0.000133	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CHST5—colon cancer	1.46e-05	0.000133	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—colon cancer	1.42e-05	0.00013	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—colon cancer	1.38e-05	0.000126	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—colon cancer	1.38e-05	0.000126	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—colon cancer	1.31e-05	0.00012	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—colon cancer	1.29e-05	0.000118	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—colon cancer	1.29e-05	0.000118	CbGpPWpGaD
Topiramate—CA4—Metabolism—EP300—colon cancer	1.29e-05	0.000118	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—colon cancer	1.25e-05	0.000114	CbGpPWpGaD
Topiramate—CA2—Metabolism—EP300—colon cancer	1.23e-05	0.000113	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—colon cancer	1.19e-05	0.000109	CbGpPWpGaD
Topiramate—CA1—Metabolism—EP300—colon cancer	1.18e-05	0.000108	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—colon cancer	1.13e-05	0.000103	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—colon cancer	1.13e-05	0.000103	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—colon cancer	1.05e-05	9.64e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—colon cancer	1.05e-05	9.64e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—EP300—colon cancer	1.04e-05	9.52e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.99e-06	9.15e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—colon cancer	9.75e-06	8.93e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—colon cancer	9.52e-06	8.71e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—colon cancer	9.13e-06	8.35e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—colon cancer	8.75e-06	8.01e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.86e-06	7.19e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—colon cancer	7.78e-06	7.12e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—colon cancer	7.69e-06	7.04e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—colon cancer	7.46e-06	6.82e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—colon cancer	7.15e-06	6.54e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.54e-06	5.98e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—colon cancer	6.4e-06	5.85e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—colon cancer	6.28e-06	5.75e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TYMS—colon cancer	6.28e-06	5.75e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.84e-06	4.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—colon cancer	4.45e-06	4.07e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—colon cancer	3.85e-06	3.52e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TYMS—colon cancer	3.78e-06	3.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—colon cancer	3.5e-06	3.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—EP300—colon cancer	2.91e-06	2.66e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—colon cancer	2.68e-06	2.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—colon cancer	2.15e-06	1.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—colon cancer	2.1e-06	1.93e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—colon cancer	1.76e-06	1.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—EP300—colon cancer	1.75e-06	1.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—colon cancer	1.29e-06	1.19e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—colon cancer	1.06e-06	9.68e-06	CbGpPWpGaD
